You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Name: Luk Van Parijs
Position: Assistant Professor at MIT’s Center for Cancer Research
Background: BA with honors, natural sciences, University of Cambridge — 1991 PhD, immunology, Harvard University — 1997 Assistant professor, MIT — 2000-present
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.
The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.
The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.
In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.
This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.
Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function.